Compass Pathways (MEX:CMPSN) Total Long-Term Assets: MXN504.05 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:CMPSN Compass Pathways PLC MEX:CMPSN
12 GF Score
Price MXN242.00
! 1 Warning Sign
View Full Analysis

What is Compass Pathways Total Long-Term Assets?

Compass Pathways MEX:CMPSN 12 Total Long-Term Assets is MXN504.05 Mil as of Jun. 2026. GuruFocus rates MEX:CMPSN with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Compass Pathways's Total Long-Term Assets for the quarter that ended in Jun. 2026 was MXN504.05 Mil.

Compass Pathways Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for Compass Pathways's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Compass Pathways Total Long-Term Assets Chart

Compass Pathways Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Long-Term Assets
Get a 7-Day Free Trial 114.84 110.02 249.37 258.09 339.57

Compass Pathways Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 322.60 242.49 339.57 376.38 504.05
MEX:CMPSN
12GF Score
Compass Pathways PLC MEX:CMPSN
Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Compass Pathways Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of MXN504.05 Mil mean?
Compass Pathways (MEX:CMPSN) has a Total Long-Term Assets of MXN504.05 Mil as of Jun. 2026. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Compass Pathways and its competitors.
Is Compass Pathways' Total Long-Term Assets too high?
Compass Pathways' current Total Long-Term Assets is MXN504.05 Mil. Overall, Compass Pathways has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Compass Pathways' Total Long-Term Assets compare to ARDT and HCSG?
Compass Pathways' Total Long-Term Assets of MXN504.05 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Healthcare Providers & Services company?
A good Total Long-Term Assets depends on the Healthcare Providers & Services industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Compass Pathways and its competitors. Compass Pathways's current Total Long-Term Assets is MXN504.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Compass Pathways stock overvalued right now?
Compass Pathways (MEX:CMPSN) has a current Total Long-Term Assets of MXN504.05 Mil. The current Total Long-Term Assets is MXN504.05 Mil. Compass Pathways' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For Compass Pathways (MEX:CMPSN), the current Total Long-Term Assets is MXN504.05 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Compass Pathways Business Description

Other Exchanges CMPS:USA5Y6:Germany
Address 33 Broadwick Street, London, GBR, W1F 0DQ
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
12GF Score

Get the complete analysis for MEX:CMPSN

Total Long-Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN242.00
Price